文献速递免疫规划传染病防控与疫情报告

以乙肝核心抗原病毒样颗粒为新型载体的脑膜炎球菌多糖结合疫苗可诱导持久且强的细胞免疫应答

Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
PubMed 文献 · Vaccine · 2019-01-14

本研究以全长乙肝核心抗原病毒样颗粒(HBc VLPs)为新型载体蛋白,通过不同长度(2、5、10 kDa)的异双功能聚乙二醇(PEG)连接子偶联脑膜炎球菌C群多糖(CPS),并全面表征了结合疫苗的理化性质。免疫实验显示,与单纯CPS及CPS与HBc物理混合物相比,结合疫苗诱导的CPS特异性IgG滴度提高约10倍并具显著加强效应,且HBc偶联诱导Th1型细胞免疫偏移(IgG2a亚类增加),同时增强抗体亲和力功能并诱导持久免疫记忆。

要点

  • HBc VLPs可作为脑膜炎球菌多糖结合疫苗的新型载体蛋白。
  • 结合疫苗诱导的CPS特异性IgG滴度较单纯CPS提高约10倍。
  • HBc偶联诱导Th1型细胞免疫应答并增强抗体亲和力与免疫记忆。

核心结论

  • HBc VLPs可作为潜在载体蛋白用于开发能诱导持久且强细胞免疫应答的多糖结合疫苗。

研究设计与样本

  • 研究以全长HBc VLPs为载体,通过2、5、10 kDa的异双功能PEG连接子偶联脑膜炎球菌C群多糖(CPS),并对结合疫苗进行理化表征与免疫评价。

主要发现

  • TEM、DLS、天然琼脂糖凝胶电泳和HPLC分析均证实偶联成功。
  • 与单纯CPS及CPS与HBc物理混合物相比,结合疫苗免疫后CPS特异性IgG滴度提高约10倍并具显著加强效应。
  • HBc偶联诱导Th1型细胞免疫偏移,表现为IgG2a亚类产量增加。
  • 结合疫苗诱导增强的抗体亲和力功能及持久免疫记忆。
  • CPS-P2k-HBc、CPS-P5k-HBc和CPS-P10k-HBc在第18周诱导的IgG滴度分别维持峰值的38.1%、17.9%和33.3%。

临床怎么用

  • 提示HBc VLPs作为载体蛋白可能用于开发诱导持久细胞免疫的脑膜炎球菌多糖结合疫苗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neisseria meningitidis caused meningitis is life-threatening acute infection with high fatality and high frequency of severe sequelae. Meningococcal capsular polysaccharides can be used to prevent meningococcal disease; while conjugating the polysaccharides to carrier protein was found necessary to improve the immunogenicity and induce memory responses in infants and young children. Nevertheless, repeated administration of glycoconjugate vaccines might lead to carrier-induced epitope suppression due to limited number of carrier proteins. Here in this study, full-length hepatitis B core antigen virus-like particles (HBc VLPs) was used as a novel potential carrier protein for conjugation of meningococcal group C polysaccharides (CPS) with heterobifunctional polyethylene glycol (PEG) of different length (2, 5 and 10 kDa) as linkers. The physiochemical properties of the CPS-PEG-HBc conjugate vaccines were fully characterized. The TEM, DLS, native agarose gel electrophoresis, and HPLC analyses all confirmed the successful conjugation. As compared to plain CPS and the physical mixture of CPS and HBc, the immunization with the conjugate vaccines can generate about 10 times increase in CPS specific IgG titers with a significant boosting effect. HBc conjugation induced a shift to a Th1 cellular immune type response, as assessed by the increased IgG2a subclass production. In addition, vaccination of the conjugate vaccines elicited much enhanced avidity functional antibody and long-lasting immunological memory. IgG titers elicited by CPS-P2k-HBc, CPS-P5k-HBc and CPS-P10k-HBc at week 18 maintained 38.1%, 17.9% and 33.3% of their peak values. All these results demonstrated that HBc VLPs can be used as potential carrier protein to develop polysaccharide conjugate vaccines effective in eliciting long-lasting and strong cellular immune response.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Xu L, Li Z, Su Z, et al. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein. Vaccine. 2019. PMID: 30655174. doi:10.1016/j.vaccine.2018.12.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。